Sort
25,944 grants matching “neurodegeneration”
Design And Development Of Experimental Therapeutics
$1,266,468Nigel H. Greig · National Institute On Aging · ZIA · FY2014 · AG
Mitochondrial Proteins in Parkinson's Disease
$1,265,705J Timothy Greenamyre · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · NS
Tissue Injury and Inflammation in Multiple Sclerosis
$1,264,874Cleveland Clinic Lerner Col/Med-Cwru · P01 · FY2005 · NS
Mitochondrial Proteins in Parkinson's Disease
$1,263,110J Timothy Greenamyre · University Of Pittsburgh At Pittsburgh · P01 · FY2011 · NS
Connecting late-life depression and cognition with statistical physics based connectomics and sparse Frechet regression
$1,261,160Alex Leow · University Of Illinois At Chicago · RF1 · FY2021 · MH
Mitochondrial Proteins in Parkinson's Disease
$1,260,589J Timothy Greenamyre · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · NS
Physiologic and Pathologic Coupling in the Neurovascular Unit
$1,260,351Eng H. Lo · Massachusetts General Hospital · P01 · FY2010 · NS
PET Study of Biochemistry and Metabolism of the CNS
$1,259,909University Of Michigan At Ann Arbor · P01 · FY2001 · NS
Amadorins for Ameliorating Alzheimer's Disease and Related Dementias (ADRD)
$1,259,042Raja G Khalifah · Praetego, Inc. · R44 · FY2022 · AG
Low Level Laser Therapy in Alzheimer's Disease
$1,258,998Quanguang Zhang · Augusta University · RF1 · FY2018 · AG
PET Study of Biochemistry and Metabolism of the CNS
$1,258,100Kirk A Frey · University Of Michigan At Ann Arbor · P01 · FY2010 · NS
PET Study of Biochemistry and Metabolism of the CNS
$1,258,085Kirk A Frey · University Of Michigan At Ann Arbor · P01 · FY2012 · NS
PET Study of Biochemistry and Metabolism of the CNS
$1,258,085Kirk A Frey · University Of Michigan At Ann Arbor · P01 · FY2011 · NS
CMP3: A CSF Multiple Pathophysiology Panel for Clinical Trials in Alzheimer's Disease
$1,256,900Steven E Arnold · Massachusetts General Hospital · RF1 · FY2018 · AG
The role of the Cockayne syndrome protein
$1,256,718Vilhelm A Bohr · National Institute On Aging · ZIA · FY2021 · AG
Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild
$1,256,516Jeffrey L Ives · Acumen Pharmaceuticals, Inc. · U01 · FY2018 · AG
Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild Alzheimer Disease
$1,256,516Eric Siemers · Acumen Pharmaceuticals, Inc. · U01 · FY2018 · AG
Physiologic and Pathologic Coupling in the Neurovascular Unit
$1,255,685Eng H. Lo · Massachusetts General Hospital · P01 · FY2011 · NS
Sex-Specific Single Cell Expression Profiles, Genetic Risk and Drug Responsiveness in Alzheimer's Disease
$1,255,679Stephen M Strittmatter · Yale University · R56 · FY2021 · AG
Sex-Specific Single Cell Expression Profiles, Genetic Risk and Drug Responsiveness in Alzheimer's Disease
$1,255,677Stephen M Strittmatter · Yale University · R56 · FY2022 · AG
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
$1,254,529Russell M Lebovitz · Amprion, Inc. · SB1 · FY2016 · NS
Novel platform for research brain banking and characterization using integrated traditional and quantitative analyses to promote precision neuropathology of Alzheimer's disease
$1,254,307Christopher D Keene · Allen Institute · U19 · FY2023 · AG
Fluorescence Microscopy
$1,254,063Charles Tucker · National Institute Of Environmental Health Sciences · ZIC · FY2023 · ES
MECHANISMS UNDERLYING MICROGLIA DYSFUNCTION DURING NEURODEGENERATION
$1,253,887Elizabeta Gjoneska · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Connectomic imaging in familial and sporadic frontotemporal degeneration
$1,253,197Murray Grossman · University Of Pennsylvania · U01 · FY2016 · AG